mannose. After solubilization in Triton X-100, cell extracts were immunoprecipitated with serum from a patient containing autoantibodies to the insulin receptor. NaDodSO4/polyacrylamide gel electrophoresis of the immunoprecipitates under reducing conditions showed the presence of major labeled subunits of apparent Mr 134,000 and 98,000 and a minor component Of Mr 206,000. The ratio of activity in the 134,000 versus 98,000 Mr bands varied from 2:1 for mannose to 1.2:1 for galactose. In addition, the receptor subunits could be demonstrated when the cell surface of intact lymphocytes was labeled with NaB3H4 by using either the galactose oxidase (acts on nonreducing terminal galactose and N-acetylgalactosamine) technique or the periodate (oxidizes sialic acid) technique. With the periodate treatment, NaB3H4 labeled preferentially the Mr 98,000 band. With the galactose oxidase procedure, on the other hand, NaB3H4 labeled only the Mr 134,000 band; prior treatment with neuraminidase increased the labeling of this band and also revealed the Mr 98,000 subunit. These data demonstrate that the major subunits of the insulin receptor are complex glycoproteins that have differences in the nonreducing ends of the carbohydrate chains. In the Mr 134,000 subunit, there appear to be more exposed galactosyl or N-acetylgalactosaminyl (or both) residues, whereas the Mr 98,000 subunit appears to have a higher degree of sialylation. These labeling techniques provide new tools to examine the role of the carbohydrate moiety in insulin receptor function and turnover.
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Most, if not all, cell surface proteins and receptors are believed to contain covalently attached carbohydrate side chains-i.e., they are glycoproteins. Along these lines, the insulin receptor, an integral membrane protein (1) , is also believed to be glycosylated. This suggestion was first made based on studies that showed impairment ofinsulin binding after digestion offat cells with glycosidases (2) and on the observation that concanavalin A and wheat germ agglutinin alter insulin binding and exhibit insulin-like effects (3) . Furthermore, complexes of both lectins linked to agarose retain the solubilized insulin receptor (3) . Recently, the interaction ofthe solubilized insulin receptor with a panel of 12 different lectins was studied and, on this basis, it was suggested that the carbohydrate moiety contains mainly Nacetylglucosamine, galactose, and mannose (4) .
To characterize directly the glycosylation of the insulin receptor, we have biosynthetically labeled the receptor of cultured human lymphocytes (IM-9 line) with tritiated monosaccharides or externally labeled the receptor by using procedures that preferentially react with galactose and sialic acid residues (5) (6) (7) (8) . To detect the insulin receptor, we used immunoprecipitation with sera from patients who have type B insulin resistance and acanthosis nigricans that contain autoantibodies that react specifically with the receptor for insulin (9) (10) (11) . These studies not only directly reveal the glycoprotein nature of both major receptor subunits but also suggest that important differences exist in the exposed terminal carbohydrates of the two subunits.
MATERIALS AND METHODS
Cell Culture and Labeling with Tritiated Monosaccharides. Human lymphocytes ofthe IM-9 line were grown in continuous culture in RPMI 1640/10% fetal calf serum/25 mM Hepes (12) . After a stationary phase of growth was reached, the cells were collected by centrifugation at 600 x g and resuspended in the same medium at 0. External Labeling with Tritiated Borohydride. The cell surface ofIM-9 lymphocytes was labeled with NaB3H4 by using two different procedures. Terminal nonreducing galactose and Nacetylgalactosamine were labeled by sequential exposure to galactose oxidase and NaB3H4 as described by Morell and Ashwell (5) for soluble glycoproteins and adapted for cell surface labeling by Gahmberg and Hakomori (6) . In brief, IM-9 lymphocytes (108 cells) were suspended in 1 ml of Dulbecco's phosphate-buffered saline and treated with 10 units of galactose oxidase (EC 1.1.3.9, Dactylium dendroides, type V; Sigma) for 30 min at 37°C in the absence or in the presence of 0.25 units of neuraminidase (EC 3.2.1.18, Vibrio cholerae, Calbiochem). The reaction was stopped by washing the cells three times with cold buffer. The aldehyde groups were then reduced by treatment with NaB3H4 (1 mCi/ml, 64 Ci/mmol; New England Nuclear) for 30 min at 22°C.
Sialic acid residues were labeled by mild oxidation with metaperiodate and subsequent reduction with NaB3H4 as described by Van Lenten and Ashwell (7) for soluble glycoproteins and modified for cell surface labeling by Gahmberg and Andersson (8) . In this case, 108 cells were incubated with 1 mM sodium metaperiodate at 0°C in the dark for 5 min. The reaction was then quenched by addition of 0.4 ml of 0.1 M glycerol in phosphate-buffered saline, and the cells were washed and treated with NaB3H4 as above. Cell Solubilization and Lectin Chromatography. After biosynthetic or external labeling, IM-9 lymphocytes were washed three times with cold phosphate-buffered saline and then suspended in 50 mM Hepes, pH 7.6/2 mM phenylmethylsulfonyl fluoride (containing bacitracin at 100 units and aprotinin at 1000 trypsin inhibitor units/ml). The suspension was continuously stirred for 1 hr in 1% (vol/vol) Triton X-100 at 220C. Undissolved material was removed by centrifugation at 200,000 x g for 90 min, and the supernatants were either used directly for immunoprecipitation or applied to 3-ml columns containing wheat germ agglutinin coupled to agarose (Miles); after extensive washing with 0.15 M NaCV50 mM Hepes/0.1% Triton, pH 7.6, bound material was eluted by addition to the buffer of 0.3 M N-acetylglucosamine. Fractions containing the highest amounts of radioactivity were pooled and used for immunoprecipitation.
Immunoprecipitation of Insulin Receptors and NaDodSO4
Polyacrylamide Gel Electrophoresis. The procedure for immunoprecipitating the solubilized insulin receptor by using sera from patients who have the type B syndrome of insulin resistance and acanthosis nigricans has been described (11) . In our experiments, labeled samples were incubated with either antireceptor serum (1:400 or 1:800 dilution) or with nonimmune serum (control). After 4 hr at 40C, sheep anti-human IgG serum (titer 2 mg/ml) was added as second antibody and the incubation was continued for 4 additional hr at 4°C. The precipitates were collected by centrifugation (10,000 X g, 5 min) and washed twice with cold 50 mM Hepes/0. 1% Triton. With antiserum B-2, we have previously shown that, at a 1:400 dilution, there is complete immunoprecipitation of solubilized insulin receptors (11) .
Immunoprecipitates were solubilized by boiling for 3 Analysis of the biosynthetically labeled insulin receptor by NaDodSOJpolyacrylamide gel electrophoresis and autoradiography showed three bands (Fig. 1 Left) . The two major bands in the antireceptor serum precipitate (lane a) had Mr 134,000 + 2,000 (SD, n = 3) and 98,000 + 1,500 (SD, n = 3). In addition, there was a minor component of Mr = 206,000 + 2,500 (SD, n = 3). The control serum precipitated only two minor bands of Mr 116,000 and 40,000 (lane b), which were also observed with the antireceptor serum. To further evaluate the specificity of the immunoprecipitation of the labeled bands, we preincubated the samples with 1.7 uM insulin before immunoprecipitation. It has previously been shown that the binding of these antireceptor antibodies to the insulin receptor is reduced by the presence ofinsulin bound to the receptor (10, 11) . Insulin effectively inhibited immunoprecipitation of all three subunits (Fig. 1 Middle) . Quantitatively, as judged by assaying the eluted radioactivity, insulin reduced the intensity of the three bands by 30% when a 1:400 dilution of the antiserum was used for precipitation (lanes c and d) and by 65% at 1:800 dilution of antiserum (lanes e and f). Two other findings also indicated that the labeled proteins were subunits of the insulin receptor. Fig. 2 shows that sera from five different patients who have antibodies to the insulin receptor precipitated the same labeled bands, and the extent of precipitation correlated well with their titer of antireceptor antibodies. Furthermore, when IM-9 lymphocytes were incubated with 0.1 AM insulin for 15 hr, the labeling of both the Mr 134,000 and the Mr 98,000 subunits was markedly decreased (Fig. 1 Right) . This treatment is known to decrease the number of insulin receptors and has been termed "down regulation" (14, 15 labeled by using the galactose oxidase/NaB3H4 method, which acts on terminal galactosyl and N-acetylgalactosaminyl residues. The cells were then solubilized in Triton X-100 and immunoprecipitation with antireceptor and control sera was performed without prior purification by lectin chromatography. Incubation with galactose oxidase alone followed by borohydride reduction labeled only the Mr 134,000 subunit ofthe insulin receptor (Fig.  4, lane c) . Treatment with galactose oxidase plus neuraminidase enhanced the labeling of this band and also revealed the Mr 98,000 subunit and the Mr 206,000 component (Fig. 4, lane a) . No labeling of the receptor occurred when cells were reduced with NaB3H4 without prior enzyme treatment (Fig. 4, lane e) .
To reveal the terminal sialic acid residues, IM-9 lymphocytes were labeled by using the periodate/NaB3H4 method, and then the cells were processed as after the galactose oxidase procedure. Fig. 5 (lane a) shows that, after periodate treatment, NaB3H4 preferentially labeled the Mr 98,000 subunit, although a faint Mr 134,000 band was also observed. When the cells were 4 . NaDodSO4/polyacrylamide gel electrophoresis and autoradiography of insulin receptors externally labeled by using the galactose oxidase/NaB3H4 procedure. Intact IM-9 lymphocytes were incubated with galactose oxidase with and without neuraminidase and then reduced with NaB3H4. After solubilization, insulin receptors were immunoprecipitated directly from the cell extracts without prior purification and analyzed electrophoretically. Lanes: c and d, galactose oxidase/NaB3H4; a and b, galactose oxidase plus neuraminidase, then NaB3H4; e and f, NaB3H4 only. Immunoprecipitation was performed with antireceptor serum B-2 (lanes a, c, and e) and with nonimmune control serum (lanes b, d, and I).
treated with neuraminidase prior to labeling (lane c), the intensity of the Mr 98,000 band decreased by 35% (as estimated from the radioactivity) while that of the Mr 134,000 component disappeared. Thus, as reported for other glycoproteins (16, 17) , sialic acid residues that are radiolabeled by this method may not all be accessible to neuraminidase. DISCUSSION Our data show that the insulin receptor of human lymphocytes contains two major glycosylated subunits (Mr = 134,000 and Mr = 98,000). Both subunits are revealed by biosynthetic and surface carbohydrate-labeling techniques, indicating that both of these subunits possess a portion of their carbohydrates exposed to the external surface ofthe cell. A similar subunit composition has previously been shown by biosynthetic labeling with [3S]-methionine (18) .
The ability to recognize the labeled insulin receptor subunits depends on our ability to specifically immunoprecipitate them by using an autoantibody to the receptor. The specificity of the autoantibodies to the receptor from patients who have the type B syndrome of acanthosis nigricans and insulin resistance is based on a number of studies (9) (10) (11) , the most convincing of which is the recent demonstration by affinity crosslinking that these antibodies recognize the same subunits as insulin itself (19) . Further evidence that these bands are subunits of the insulin receptor is provided by the fact that their immunoprecipitation is inhibited by unlabeled insulin and markedly reduced after down regulation of the cells, a process known to decrease the number of insulin binding sites (14, 15 odate/NaB H4 method. Intact IM-9 lymphocytes were treated with 1 mM sodium metaperiodate at 0°C and then reduced with NaB3H4 and analyzed as in described in the legend to Fig. 4 (lanes a and b) . Lanes c and d, cells were treated with neuraminidase prior to labeling. Immunoprecipitation was performed with antireceptor serum B-2 (lanes a and c) and nonimmune control serum (lanes b and d). (20) (21) (22) and chemical crosslinking agents that covalently link radiolabeled insulin to its receptor (19, 23, 24) .
The presence of a minor band Of Mr 206,000 has been shown by both [3S]methionine labeling (18) and glycoprotein labeling methods. A similar band has also been detected in studies using affinity-labeling techniques when the receptor is only partially reduced before electrophoresis. This has led to the suggestion that the insulin receptor has an immunoglobulin-like structure with heavy and light chains held together by disulfide bonds (19, 25, 26 (25, 27) , which is also thought to be a glycoprotein based on a change in electrophoretic mobility after treatment with neuraminidase (25) However, the cells were incubated in medium containing a high glucose concentration (11 mM), which presumably avoided any "glucose starvation" effect on the carbohydrate metabolic pathways. Thus, it is not unreasonable to postulate that most of the glucosamine was used to form N-acetylglucosamine, N-acetylgalactosamine, and sialic acid while galactose, fucose, and mannose were incorporated, at least in part, unmodified (28, 29) . Differences in the relative specific activities oflabeling ofthe major subunits were observed with the different monosaccharides. With galactose, the ratio ofradioactivity in the Mr 134,000 and Mr 98,000 bands was 1.2:1 whereas, with the three other tritiated monosaccharides, the ratios were 1.8:1-2:1. Assuming that both subunits are synthesized from the same precursor pools, this suggests that some differences in carbohydrate composition may exist. The incorporation of all four labeled monosaccharides into both subunits also suggests that both probably contain carbohydrate chains ofthe complex, N-linked type (30) . This suggestion is in good agreement with findings of differential lectin binding (4) and with the observation that tunicamycin, an antibiotic that blocks glycosylation of N-linked glycoproteins, induces a depletion of insulin binding activity in 3T3-L1 cells (31) . However, the possible presence of O-linked carbohydrate chains in the receptor subunits cannot be excluded.
The external labeling techniques revealed remarkable differenceslin the nonreducing termini of the carbohydrate chains of both major subunits. The galactose oxidase/NaB3H4 procedure preferentially labeled the Mr 134,000 subunit, whereas the periodate/NaB3H4 method preferentially labeled the Mr 98,000 band. These findings suggest that there are more terminal galactose and N-acetylgalactosamine residues present or accessible in the Mr 134,000 subunit, whereas the Mr 98,000 component has more exposed sialic acid residues. The different behavior of the subunits with external labeling makes unlikely the possibility that the Mr 98,000 subunit is simply a fragment of the Mr 134,000 component.
In summary, both major subunits of the insulin receptor are glycoproteins and can be labeled biosynthetically or externally. These techniques provide new tools to examine the role of the carbohydrate moiety of the insulin receptor in its expression, function, and turnover.
